Latest news with #CVSGroup
Yahoo
21-07-2025
- Business
- Yahoo
3 Top Undervalued Small Caps In The European Market With Insider Action
As the European market navigates a period of mixed performance, with the pan-European STOXX Europe 600 Index remaining relatively flat amidst ongoing trade discussions and economic adjustments, small-cap stocks present intriguing opportunities for investors. In this environment, identifying stocks that exhibit strong fundamentals and potential for growth can be particularly rewarding, especially when insider activity suggests confidence in their future prospects. Top 10 Undervalued Small Caps With Insider Buying In Europe Name PE PS Discount to Fair Value Value Rating Kitwave Group 13.0x 0.3x 45.16% ★★★★★☆ Instabank 10.2x 2.9x 24.22% ★★★★★☆ Yubico 32.7x 4.7x 11.32% ★★★★☆☆ Hoist Finance 8.9x 1.8x 18.02% ★★★★☆☆ CVS Group 45.1x 1.3x 38.97% ★★★★☆☆ Seeing Machines NA 2.9x 45.04% ★★★★☆☆ A.G. BARR 19.5x 1.8x 46.10% ★★★☆☆☆ NOTE 21.1x 1.4x -8.45% ★★★☆☆☆ FastPartner 17.0x 4.4x -35.94% ★★★☆☆☆ Karnov Group 233.1x 5.0x 27.51% ★★★☆☆☆ Click here to see the full list of 53 stocks from our Undervalued European Small Caps With Insider Buying screener. Let's dive into some prime choices out of from the screener. CVS Group Simply Wall St Value Rating: ★★★★☆☆ Overview: CVS Group operates in the veterinary services industry, providing services through its veterinary practices, laboratories, crematoria, and online retail business, with a market capitalization of approximately £1.32 billion. Operations: The primary revenue streams are Veterinary Practices, Laboratories, and Online Retail Business. The gross profit margin has shown variability over time, with a recent figure of 44.23%. Operating expenses have been significant, particularly in General & Administrative costs. PE: 45.1x CVS Group, a European small-cap company, is currently trading at levels that suggest it might be undervalued. Despite a decline in profit margins from 7.3% to 2.9% over the past year, there's insider confidence reflected in recent share purchases within the last six months. Earnings are projected to grow by 19% annually, although interest payments aren't fully covered by earnings due to reliance on external borrowing for funding. This financial structure presents both opportunities and challenges for future growth potential. Navigate through the intricacies of CVS Group with our comprehensive valuation report here. Explore historical data to track CVS Group's performance over time in our Past section. Alimak Group Simply Wall St Value Rating: ★★★★☆☆ Overview: Alimak Group specializes in providing vertical access solutions, including elevators and platforms for industrial and construction sectors, with a market cap of approximately SEK 5.18 billion. Operations: Alimak Group generates revenue primarily through its sales, with a notable gross profit margin trend peaking at 40.81% by mid-2025. The company's cost structure is significantly influenced by the cost of goods sold (COGS), which has shown an upward trajectory over time. Operating expenses, including sales and marketing, research and development, and general administrative costs, also play a crucial role in determining profitability. Net income margins have demonstrated variability but reached 10.11% in mid-2025, indicating improved efficiency in managing expenses relative to revenue growth. PE: 23.1x Alimak Group, a small European company, recently reported improved earnings with net income for Q2 2025 at SEK 184 million, up from SEK 143 million the previous year. Despite stable sales figures around SEK 1.7 billion for both quarters, the company's basic earnings per share rose to SEK 1.74 from SEK 1.35 year-on-year. Insider confidence is evident as Sven Törnkvist increased their stake by purchasing an additional 4,000 shares in June for approximately A$451,440. With earnings projected to grow annually by over 10%, Alimak's prospects appear promising despite its reliance on external borrowing as a funding source. Get an in-depth perspective on Alimak Group's performance by reading our valuation report here. Examine Alimak Group's past performance report to understand how it has performed in the past. BHG Group Simply Wall St Value Rating: ★★★★☆☆ Overview: BHG Group is a leading Nordic online retailer specializing in home improvement and furniture, with a market capitalization of approximately SEK 3.5 billion. Operations: BHG Group generates revenue primarily through sales, with recent figures showing SEK 10.25 billion for the quarter ending June 2025. The company's gross profit margin was noted at 17.12% during this period, indicating a focus on managing cost of goods sold relative to revenue. Operating expenses include significant allocations for general and administrative purposes, totaling SEK 1.09 billion in the same quarter. PE: -11.1x BHG Group, a European small cap, has shown promising financial recovery with net income reaching SEK 75.6 million in Q2 2025, reversing a loss from the previous year. Earnings per share improved to SEK 0.42 from a loss of SEK 0.57. Notably, insider confidence is evident as Martin Leo purchased shares worth over SEK 1 million recently, reflecting potential optimism about future growth prospects despite reliance on external borrowing for funding and anticipated earnings growth of nearly 88% annually. Take a closer look at BHG Group's potential here in our valuation report. Understand BHG Group's track record by examining our Past report. Key Takeaways Navigate through the entire inventory of 53 Undervalued European Small Caps With Insider Buying here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:CVSG OM:ALIG and OM:BHG. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
26-06-2025
- Business
- Yahoo
UK's June 2025 Stock Picks Estimated Below Intrinsic Value
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China, highlighting concerns over global economic recovery. As investors navigate these turbulent times, identifying undervalued stocks becomes crucial; such stocks may offer potential opportunities by trading below their intrinsic value amidst broader market uncertainties. Name Current Price Fair Value (Est) Discount (Est) Vistry Group (LSE:VTY) £6.258 £10.78 41.9% LSL Property Services (LSE:LSL) £3.14 £5.64 44.4% Jubilee Metals Group (AIM:JLP) £0.035 £0.065 45.9% Informa (LSE:INF) £8.086 £14.49 44.2% Huddled Group (AIM:HUD) £0.035 £0.06 41.4% Hostelworld Group (LSE:HSW) £1.365 £2.60 47.5% Gooch & Housego (AIM:GHH) £6.00 £10.56 43.2% Franchise Brands (AIM:FRAN) £1.48 £2.56 42.3% Deliveroo (LSE:ROO) £1.758 £3.06 42.5% AstraZeneca (LSE:AZN) £102.48 £178.94 42.7% Click here to see the full list of 49 stocks from our Undervalued UK Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. Overview: CVS Group plc operates in the veterinary, pet crematoria, online pharmacy, and retail sectors with a market cap of £905.36 million. Operations: The company's revenue is primarily derived from its Veterinary Practices (£600.50 million), Online Retail Business (£48.50 million), Laboratories (£30.90 million), and Crematoria (£12.20 million) segments. Estimated Discount To Fair Value: 31.4% CVS Group is trading at £12.62, significantly below its estimated fair value of £18.4, suggesting it is undervalued based on discounted cash flow analysis. Analysts predict a 21.5% stock price increase and expect earnings to grow annually by 21.1%, outpacing the UK market's 13.8%. However, interest payments are not well covered by earnings, and profit margins have declined from 7.3% to 2.9% over the past year. The analysis detailed in our CVS Group growth report hints at robust future financial performance. Take a closer look at CVS Group's balance sheet health here in our report. Overview: Nichols plc, with a market cap of £506.49 million, supplies soft drinks to the retail, wholesale, catering, licensed, and leisure industries in the United Kingdom and internationally including the Middle East and Africa. Operations: The company's revenue is derived from two main segments: Packaged, generating £132.82 million, and Out of Home, contributing £39.99 million. Estimated Discount To Fair Value: 23.7% Nichols plc, trading at £13.85, is undervalued by over 20% against its estimated fair value of £18.15 based on discounted cash flow analysis. Despite a slower forecasted revenue growth of 3.9% annually compared to the broader market, Nichols' earnings are expected to grow faster than the UK average at 14.8% per year. Recent trading results show stable performance with strategic shifts in international operations and limited exposure to global tariff changes, supporting continued profitable growth ambitions. According our earnings growth report, there's an indication that Nichols might be ready to expand. Unlock comprehensive insights into our analysis of Nichols stock in this financial health report. Overview: SSP Group plc operates food and beverage outlets across various regions including North America, Europe, the UK, Ireland, Asia Pacific, Eastern Europe, and the Middle East with a market cap of approximately £1.35 billion. Operations: The company's revenue primarily comes from its food and beverage travel sector, mainly at airports and railway stations, amounting to £3.58 billion. Estimated Discount To Fair Value: 37.6% SSP Group, trading at £1.68, is significantly undervalued with a fair value estimate of £2.70 based on discounted cash flow analysis. Despite reporting a net loss of £61.5 million for H1 2025, SSP's earnings are forecast to grow substantially by 57.53% annually and the company is expected to become profitable in three years. The stock also trades at good value relative to peers and industry standards, highlighting its potential as an undervalued opportunity. Our expertly prepared growth report on SSP Group implies its future financial outlook may be stronger than recent results. Dive into the specifics of SSP Group here with our thorough financial health report. Access the full spectrum of 49 Undervalued UK Stocks Based On Cash Flows by clicking on this link. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:CVSG AIM:NICL and LSE:SSPG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-06-2025
- Business
- Yahoo
CVS Health Corporation (CVS): A Bull Case Theory
We came across a bullish thesis on CVS Health Corporation on Microcapexpert's Substack. In this article, we will summarize the bull's thesis on CVS. CVS Health Corporation's share was trading at $67.58 as of June 24th. CVS's trailing and forward P/E ratios were 16.13 and 11.49, respectively, according to Yahoo Finance. A healthcare professional in a meeting with a patient discussing care options using digital technology. The UK's Competition and Markets Authority (CMA) has published its initial findings on the veterinary services market, and the proposed remedies appear relatively mild for CVS Group. While the CMA highlights the need for improved price transparency, there are no indications of harsh regulatory actions that could threaten CVS's profitability or operational structure. This early outcome validates previous expectations that the regulatory scrutiny would result in limited disruption. Although these are not yet the CMA's final conclusions—with a full report expected in the coming months—the working paper offers a reliable preview of the ultimate resolution. With the regulatory overhang easing, investor sentiment has improved significantly. CVS's share price jumped 12% on the news and has now surged 50% since the start of the year. Despite this rebound, the stock still trades below the 2,000 pence level it held prior to the launch of the CMA investigation, suggesting more upside may lie ahead as the market fully digests the benign regulatory outcome. The stock's momentum is likely to continue as clarity returns and investors reprice the reduced risk profile. In the absence of severe restrictions, CVS can continue leveraging its scale and efficiencies in the UK veterinary market, and with regulatory uncertainty fading, valuation multiples may expand. For investors who were cautious due to regulatory concerns, this working paper signals a potential green light to reenter. Overall, CVS stands to benefit as regulatory fears dissipate and the market acknowledges the limited impact of the CMA's review. Previously, we covered a on CVS Health Corporation by Hidden Market Gems in April 2025, which highlighted its U.S.-centric revenues, essential offerings, and strong cash flow. The company's stock has depreciated ~4% since our coverage, as macro pressures persisted. The thesis still stands. Microcapexpert shares a similar view but emphasizes the regulatory clarity as a new catalyst. CVS Health Corporation is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 73 hedge fund portfolios held CVS at the end of the first quarter, which was 74 in the previous quarter. While we acknowledge the risk and potential of CVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Business
- Yahoo
UK Stocks Trading Below Estimated Value In May 2025
Amidst ongoing concerns about China's economic recovery and its ripple effects on global markets, the FTSE 100 and FTSE 250 indices in the United Kingdom have faced downward pressure, reflecting broader uncertainties. In such a volatile environment, identifying stocks that are trading below their estimated value can offer potential opportunities for investors looking to navigate through market fluctuations. Name Current Price Fair Value (Est) Discount (Est) Aptitude Software Group (LSE:APTD) £2.79 £5.13 45.6% Victrex (LSE:VCT) £7.98 £15.44 48.3% SDI Group (AIM:SDI) £0.71 £1.36 48% Informa (LSE:INF) £7.96 £14.50 45.1% Just Group (LSE:JUST) £1.486 £2.95 49.7% Duke Capital (AIM:DUKE) £0.2875 £0.53 45.4% Huddled Group (AIM:HUD) £0.0305 £0.06 49.1% Entain (LSE:ENT) £7.466 £13.75 45.7% Vistry Group (LSE:VTY) £6.24 £11.39 45.2% Deliveroo (LSE:ROO) £1.754 £3.04 42.4% Click here to see the full list of 53 stocks from our Undervalued UK Stocks Based On Cash Flows screener. We're going to check out a few of the best picks from our screener tool. Overview: CVS Group plc operates in veterinary services, pet crematoria, online pharmacy, and retail sectors, with a market cap of £886.71 million. Operations: The company's revenue is primarily derived from its veterinary practices (£600.50 million), online retail business (£48.50 million), laboratories (£30.90 million), and crematoria services (£12.20 million). Estimated Discount To Fair Value: 32.5% CVS Group appears undervalued, trading 32.5% below its estimated fair value of £18.32, with a current price of £12.36. Despite lower profit margins compared to last year, the company's earnings are projected to grow significantly at 24.3% annually over the next three years, outpacing the UK market average growth rate of 14.5%. However, interest payments are not well covered by earnings, which may pose financial risks despite strong revenue forecasts and analyst optimism about future price increases. Our growth report here indicates CVS Group may be poised for an improving outlook. Click here to discover the nuances of CVS Group with our detailed financial health report. Overview: Just Group plc offers a range of retirement income products and services to individuals, homeowners, and corporate clients in the United Kingdom, with a market cap of £1.54 billion. Operations: Just Group's revenue primarily stems from its diverse offerings in retirement income solutions tailored for individuals, homeowners, and corporate clients across the UK. Estimated Discount To Fair Value: 49.7% Just Group is trading at £1.49, significantly below its estimated fair value of £2.95, indicating potential undervaluation based on cash flows. Despite a drop in profit margins to 3.2% from 6.3% last year and net income falling to £80 million, earnings are forecasted to grow at 19.7% annually, surpassing the UK market average of 14.5%. Recent dividend approval highlights ongoing shareholder returns amidst robust revenue growth projections of 29% per year. According our earnings growth report, there's an indication that Just Group might be ready to expand. Click to explore a detailed breakdown of our findings in Just Group's balance sheet health report. Overview: W.A.G payment solutions plc operates an integrated payments and mobility platform targeting the commercial road transportation industry in Europe, with a market cap of £452.68 million. Operations: The company generates revenue primarily from its Payment Solutions segment, which accounts for €2.11 billion, and its Mobility Solutions segment, contributing €125.57 million. Estimated Discount To Fair Value: 24.3% W.A.G payment solutions is trading at £0.66, below its estimated fair value of £0.87, highlighting potential undervaluation based on cash flows. Despite a forecasted revenue decline of 71.6% annually over the next three years, earnings are expected to grow significantly at 34.7% per year, outpacing the UK market average growth rate. Recent guidance suggests low-teen net revenue growth for 2025, and a special dividend of 3 pence per share has been proposed pending shareholder approval. Our comprehensive growth report raises the possibility that W.A.G payment solutions is poised for substantial financial growth. Delve into the full analysis health report here for a deeper understanding of W.A.G payment solutions. Explore the 53 names from our Undervalued UK Stocks Based On Cash Flows screener here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:CVSG LSE:JUST and LSE:WPS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28-05-2025
- Business
- Yahoo
UK Stocks Trading Below Estimated Value In May 2025
Amidst ongoing concerns about China's economic recovery and its ripple effects on global markets, the FTSE 100 and FTSE 250 indices in the United Kingdom have faced downward pressure, reflecting broader uncertainties. In such a volatile environment, identifying stocks that are trading below their estimated value can offer potential opportunities for investors looking to navigate through market fluctuations. Name Current Price Fair Value (Est) Discount (Est) Aptitude Software Group (LSE:APTD) £2.79 £5.13 45.6% Victrex (LSE:VCT) £7.98 £15.44 48.3% SDI Group (AIM:SDI) £0.71 £1.36 48% Informa (LSE:INF) £7.96 £14.50 45.1% Just Group (LSE:JUST) £1.486 £2.95 49.7% Duke Capital (AIM:DUKE) £0.2875 £0.53 45.4% Huddled Group (AIM:HUD) £0.0305 £0.06 49.1% Entain (LSE:ENT) £7.466 £13.75 45.7% Vistry Group (LSE:VTY) £6.24 £11.39 45.2% Deliveroo (LSE:ROO) £1.754 £3.04 42.4% Click here to see the full list of 53 stocks from our Undervalued UK Stocks Based On Cash Flows screener. We're going to check out a few of the best picks from our screener tool. Overview: CVS Group plc operates in veterinary services, pet crematoria, online pharmacy, and retail sectors, with a market cap of £886.71 million. Operations: The company's revenue is primarily derived from its veterinary practices (£600.50 million), online retail business (£48.50 million), laboratories (£30.90 million), and crematoria services (£12.20 million). Estimated Discount To Fair Value: 32.5% CVS Group appears undervalued, trading 32.5% below its estimated fair value of £18.32, with a current price of £12.36. Despite lower profit margins compared to last year, the company's earnings are projected to grow significantly at 24.3% annually over the next three years, outpacing the UK market average growth rate of 14.5%. However, interest payments are not well covered by earnings, which may pose financial risks despite strong revenue forecasts and analyst optimism about future price increases. Our growth report here indicates CVS Group may be poised for an improving outlook. Click here to discover the nuances of CVS Group with our detailed financial health report. Overview: Just Group plc offers a range of retirement income products and services to individuals, homeowners, and corporate clients in the United Kingdom, with a market cap of £1.54 billion. Operations: Just Group's revenue primarily stems from its diverse offerings in retirement income solutions tailored for individuals, homeowners, and corporate clients across the UK. Estimated Discount To Fair Value: 49.7% Just Group is trading at £1.49, significantly below its estimated fair value of £2.95, indicating potential undervaluation based on cash flows. Despite a drop in profit margins to 3.2% from 6.3% last year and net income falling to £80 million, earnings are forecasted to grow at 19.7% annually, surpassing the UK market average of 14.5%. Recent dividend approval highlights ongoing shareholder returns amidst robust revenue growth projections of 29% per year. According our earnings growth report, there's an indication that Just Group might be ready to expand. Click to explore a detailed breakdown of our findings in Just Group's balance sheet health report. Overview: W.A.G payment solutions plc operates an integrated payments and mobility platform targeting the commercial road transportation industry in Europe, with a market cap of £452.68 million. Operations: The company generates revenue primarily from its Payment Solutions segment, which accounts for €2.11 billion, and its Mobility Solutions segment, contributing €125.57 million. Estimated Discount To Fair Value: 24.3% W.A.G payment solutions is trading at £0.66, below its estimated fair value of £0.87, highlighting potential undervaluation based on cash flows. Despite a forecasted revenue decline of 71.6% annually over the next three years, earnings are expected to grow significantly at 34.7% per year, outpacing the UK market average growth rate. Recent guidance suggests low-teen net revenue growth for 2025, and a special dividend of 3 pence per share has been proposed pending shareholder approval. Our comprehensive growth report raises the possibility that W.A.G payment solutions is poised for substantial financial growth. Delve into the full analysis health report here for a deeper understanding of W.A.G payment solutions. Explore the 53 names from our Undervalued UK Stocks Based On Cash Flows screener here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:CVSG LSE:JUST and LSE:WPS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
